Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.89
+0.59 (11.13%)
At close: Mar 6, 2026, 4:00 PM EST
5.91
+0.02 (0.34%)
After-hours: Mar 6, 2026, 6:44 PM EST
Atea Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | - | 351.37 | |
| Revenue Growth (YoY) | - | - | - | - | 622.49% | |
| Cost of Revenue | 146.53 | 83.37 | 70.61 | 62.39 | 167.21 | |
| Gross Profit | -146.53 | -83.37 | -70.61 | -62.39 | 184.16 | |
| Selling, General & Admin | 32.86 | 48.85 | 49.92 | 48.71 | 45.79 | |
| Operating Expenses | 32.86 | 48.85 | 49.92 | 48.71 | 45.79 | |
| Operating Income | -179.4 | -132.22 | -120.53 | -111.1 | 138.38 | |
| Interest & Investment Income | 16.38 | 25.49 | 29.22 | 11.15 | 0.21 | |
| EBT Excluding Unusual Items | -163.02 | -106.73 | -91.31 | -99.95 | 138.59 | |
| Other Unusual Items | -1.49 | -60.73 | -43.63 | -19.55 | - | |
| Pretax Income | -164.51 | -167.46 | -134.94 | -119.5 | 138.59 | |
| Income Tax Expense | -6.16 | 0.93 | 1.02 | -3.59 | 17.4 | |
| Net Income | -158.35 | -168.39 | -135.96 | -115.91 | 121.19 | |
| Net Income to Common | -158.35 | -168.39 | -135.96 | -115.91 | 121.19 | |
| Shares Outstanding (Basic) | 81 | 84 | 83 | 83 | 83 | |
| Shares Outstanding (Diluted) | 81 | 84 | 83 | 83 | 88 | |
| Shares Change (YoY) | -3.29% | 1.05% | 0.17% | -5.67% | 308.70% | |
| EPS (Basic) | -1.94 | -2.00 | -1.63 | -1.39 | 1.46 | |
| EPS (Diluted) | -1.94 | -2.00 | -1.63 | -1.39 | 1.37 | |
| Free Cash Flow | -132.03 | -135.5 | -85.4 | -122.93 | -87.01 | |
| Free Cash Flow Per Share | -1.62 | -1.61 | -1.02 | -1.48 | -0.99 | |
| Gross Margin | - | - | - | - | 52.41% | |
| Operating Margin | - | - | - | - | 39.38% | |
| Profit Margin | - | - | - | - | 34.49% | |
| Free Cash Flow Margin | - | - | - | - | -24.76% | |
| EBITDA | -178.98 | -131.8 | -120.11 | -110.84 | 138.41 | |
| EBITDA Margin | - | - | - | - | 39.39% | |
| D&A For EBITDA | 0.42 | 0.42 | 0.42 | 0.26 | 0.03 | |
| EBIT | -179.4 | -132.22 | -120.53 | -111.1 | 138.38 | |
| EBIT Margin | - | - | - | - | 39.38% | |
| Effective Tax Rate | - | - | - | - | 12.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.